-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, Shandong Shengdi Pharmaceutical Co., Ltd., a subsidiary of Jiangsu Hengrui Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”), received the “Notice of Acceptance” issued by the State Drug Administration (hereinafter referred to as the “State Drug Administration”), and the company's application for a drug marketing license for HRS-7535 tablets was accepted by the State Drug Administration.

Zhitongcaijing·09/02/2026 10:25:27
Listen to the news
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, Shandong Shengdi Pharmaceutical Co., Ltd., a subsidiary of Jiangsu Hengrui Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”), received the “Notice of Acceptance” issued by the State Drug Administration (hereinafter referred to as the “State Drug Administration”), and the company's application for a drug marketing license for HRS-7535 tablets was accepted by the State Drug Administration.